Page 138 - 《中国药房》2021年07期

[24] MOORE S F，VAN DEN BOSCH M T，HUNTER R W， bioavailable，potent，and high-affinity agonist of the nuc-
et al. Dual regulation of glycogen synthase kinase 3 lear receptor RORalpha（NR1F1）[J]. J Biomol Screen，
（GSK3）α/β by protein kinase C（PKC）α and Akt pro- 2014，19（3）：399-406.
motes thrombin-mediated integrin αⅡbβ3 activation and [37] HE B，NOHARA K，PARK N，et al. The small molecule
granule secretion in platelets[J]. Biol Chem，2013，288 nobiletin targets the molecular oscillator to enhance circa-
（6）：3918-3928. dian rhythms and protect against metabolic syndrome[J].
[25] BEUREL E，GRIECO S F，JOPE R S. Glycogen synthase Cell Metab，2016，23（4）：610-621.
kinase-3 （GSK3）：regulation，actions，and diseases[J]. [38] HUANG H，LI L，SHI W，et al. The multifunctional effects
Pharmacol Ther，2015，148：114-131. of nobiletin and its metabolites in vivo and in vitro[J/OL].
[26] MINAMI Y，OISHI I，ENDO M，et al. ROR-family recep- Evid Based Complement Alternat Med，2016[2020-06-02].
tor tyrosine kinases in noncanonical Wnt signaling：their https：//pubmed.ncbi.nlm.nih.gov/27761146/. DOI：10.1155/
implications in developmental morphogenesis and human 2016/2918796.
diseases[J]. Dev Dyn，2010，239（1）：1-15. [39] MULVIHILL E E，BURKE A C，HUFF M W. Citrus flavo-
[27] STRICKER S，RAUSCHENBERGER V，SCHAMBONY noids as regulators of lipoprotein metabolism and athero-
A. ROR-family receptor tyrosine kinases[J]. Curr Top Dev sclerosis[J]. Annu Rev Nutr，2016，36：275-299.
Biol，2017，123：105-142. [40] LEE J W，HIROTA T，KUMAR A，et al. Development of
[28] GRANT D，YIN L，COLLINS J L，et al. GSK4112，a small-molecule cryptochrome stabilizer derivatives as
small molecule chemical probe for the cell biology of the modulators of the circadian clock[J]. Chem Med Chem，
nuclear heme receptor Rev-erbalpha[J]. Acs Chem Biol， 2015，10（9）：1489-1497.
2010，5（10）：925-932. [41] MILLER S，AIKAWA Y，SUGIYAMA A，et al. An iso-
[29] CHEN H，ISAYAMA K，KUMAZAWA M，et al. Integra- form-selective modulator of cryptochrome 1 regulates cir-
tion of the nuclear receptor REV-ERBalpha linked with cadian rhythms in mammals[J]. Cell Chem Biol，2020，27
circadian oscillators in the expressions of Alas1， （9）：1192-1198.
Ppargc1a，and Il6 genes in rat granulosa cells[J]. Chrono- [42] DONG Z，ZHANG G，QU M，et al. Targeting glioblasto-
biol Int，2015，32（6）：739-749. ma stem cells through disruption of the circadian clock[J].
[30] CHU G，ZHOU X，HU Y，et al. Rev-erbα inhibits prolifer- Cancer Discov，2019，9（11）：1556-1573.
ation and promotes apoptosis of preadipocytes through the [43] HUMPHRIES P S，BERSOT R，KINCAID J，et al. Carba-
agonist GSK4112[J]. Int J Mol Sci，2019，20（18）：4524. zole-containing amides and ureas：discovery of crypto-
[31] DIERICKX P，EMMETT M J，JIANG C，et al. SR9009 chrome modulators as antihyperglycemic agents[J].
has REV-ERB-independent effects on cell proliferation Bioorg Med Chem Lett，2018，28（3）：293-297.
and metabolism[J]. Proc Natl Acad Sci USA，2019，116 [44] OSHIMA T，YAMANAKA I，KUMAR A，et al. C-hactiva-
（25）：12147-12152. tion generates period-shortening molecules that target
[32] ZHANG T，ZHAO M，LU D，et al. REV-ERBα regulates cryptochrome in the mammalian circadian clock[J]. An-
CYP7A1 through repression of liver receptor Homo- gew Chem Int Ed Engl，2015，54（24）：7193-7197.
log-1[J]. Drug Metab Dispos，2018，46（3）：248-258. [45] JANG J，CHUNG S，CHOI Y，et al. The cryptochrome in-
[33] LEE J，KIM D E，GRIFFIN P，et al. Inhibition of REV- hibitor KS15 enhances E-box-mediated transcription by
ERBs stimulates microglial amyloid-beta clearance and re- disrupting the feedback action of a circadian transcrip-
duces amyloid plaque deposition in the 5XFAD mouse tion-repressor complex[J]. Life Sci，2018，200：49-55.
model of Alzheimer’s disease[J]. Aging Cell，2020，19 [46] CHUN S K，CHUNG S，KIM HD，et al. A synthetic cryp-
（2）：e13078. tochrome inhibitor induces anti-proliferative effects and
[34] DE MEI C，ERCOLANI L，PARODI C，et al. Dual inhibi- increases chemosensitivity in human breast cancer cells[J].
tion of REV-ERBβ and autophagy as a novel pharmaco- Biochem Biophys Res Commun，2015，467（2）：441-446.
logical approach to induce cytotoxicity in cancer cells[J]. [47] DORUK Y U，YARPARVAR D，AKYEL Y K，et al. A
Oncogene，2015，34（20）：2597-2608. clock-binding small molecule disrupts the interaction be-
[35] KOJETIN D J，BURRIS T P. REV-ERB and ROR nuclear tween CLOCK and BMAL1 and enhances circadian
receptors as drug targets[J]. Nat Rev Drug Discov，2014， rhythm amplitude[J]. J Biol Chem，2020，295（11）：3518-
13（3）：197-216. 3531.
[36] HELLEBOID S，HAUG C，LAMOTTKE K，et al. The （收稿日期：2020-06-05 修回日期：2021-01-02）
identification of naturally occurring neoruscogenin as a （编辑：罗 瑞）

·896 · China Pharmacy 2021 Vol. 32 No. 7 中国药房 2021年第32卷第7期